Abstract
Inflammasome: a new trigger of Alzheimer's disease.
Highlights
Edited by: Fernanda Laezza, University of Texas Medical Branch, USA Reviewed by: Fernanda Laezza, University of Texas Medical Branch, USA Filippo Tempia, University of Turin, Italy
The researchers examined the differences in the level of spatial memory impairment between these groups and found that in amyloid precursor protein (APP)/PS1/NLRP3−/− and APP/PS1/Casp-1−/− mice, the level of cleaved Casp-1 was markedly decreased when compared to APP/PS1 mice, while IL-1β levels were consistent between the groups (Heneka et al, 2013)
The researchers compared the level of long-term potentiation (LTP), which is analogous to synaptic plasticity, in the hippocampi of these mice
Summary
Edited by: Fernanda Laezza, University of Texas Medical Branch, USA Reviewed by: Fernanda Laezza, University of Texas Medical Branch, USA Filippo Tempia, University of Turin, Italy. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice by Heneka, M. The main contributing factor in the development of Alzheimer’s disease is the deposition of β-amyloid in the brain, especially in the hippocampus (Heneka et al, 2013).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
